Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook
MINNEAPOLIS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter and year ended December 31, 2024.
CEO Tim Herbert told investors the company received a civil investigative demand from the Department of Justice in January ...
Inspire Medical shares dipped — but have since mostly recovered — following news of a government investigation following Q4 ...
Inspire Medical Systems said it is cooperating with U.S. Justice Department probe of allegations into allegations of false claims related to its Inspire system apnea implant. Shares fall 5.5% to $171 ...
Inspire Medical Systems, Inc. announced preliminary fourth quarter and full year 2024 financial results, revealing anticipated revenues of approximately $239.5 million to $239.7 million for Q4 ...
In a highly anticipated conference call, Inspire Medical Systems reported an impressive fourth quarter and full year 2024 ...
The promotion and reimbursement practices for the medtech company’s implantable CPAP alternative are under scrutiny.
Chairman and Chief Executive Officer of Inspire Medical Systems. “We are also excited to announce the first implants of the new Inspire V neurostimulation system, and a new organizational ...
Inspire Medical's both geographic segments witness strong revenue growth on the back of solid product demand in the fourth ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback